MSOX

Trulieve Cannabis (TRLV.US) climbed more than 7% during regular trading to $11.03.

The company announced that its state-licensed medical cannabis business has received federal registration from the U.S. Drug Enforcement Administration (DEA). The registration follows an application submitted after medical cannabis was rescheduled as a Schedule III controlled substance under the Controlled Substances Act. The DEA had previously issued preliminary federal registrations to eligible state-licensed clinics under a new federal framework ordered by the attorney general in April.

Based on public media reports. AI-generated; not investment advice.